Pharmaceutical Quality Decision Making

This webinar teaches participants about strategic decision making in Pharmaceutical Quality, highlighting the importance of careful consideration of experience and skills. Incorrect judgments can negatively impact a company's reputation and pose significant regulatory compliance risks.
  • Wednesday
  • May
  • 06
  • 2026
08:00 AM PDT | 11:00 AM EDT
Duration: 60 Minutes
IMG Saurabh Joshi
Webinar Id: 62271
Live
Session
$119.00
Single Attendee
$249.00
Group Attendees
Recorded
Session
$159.00
Single Attendee
$359.00
Group Attendees
Combo
Live+Recorded
$249.00
Single Attendee
$549.00
Group Attendees

Overview:

When leaders or the operational level staffs make small or big decision regarding the product, processes or related operations, they usually do it with the backing of their experience, skills. Such a decision may have right outcome, however, there may be situations where this might even bring unexpected outcome. This webinar will help participants to understand how the decision making in Pharmaceutical Quality should be strategized.

Why you should Attend:

An incorrect judgement regarding Quality can impact the reputation of the company and worst, it could also have a major regulatory compliance risk.

Areas Covered in the Session:

  • Areas of decision making
  • What could be a bad decision
  • How to make good decisions
  • How to validate good decisions
  • A business case study

Who Will Benefit:

  • Managers
  • Sr. Managers
  • Directors

Speaker Profile

Saurabh Joshi has over two decades of industry experience, he led quality in operations, qualifications-validations, QMS, centres of excellence, and consulting. He has studied pharmaceutical sciences and has worked with many reputed pharmaceutical companies in India and an EU based company. He has interacted with regulatory agencies from across the globe including FDA, MHRA, HPRA, WHO (Geneva) and ANVISA. At ValGenesis, Saurabh uses his domain expertise to help customer and clients unleash their true potential by going paperless and transition to Pharma 4.0 journey.